Displaying drugs 26 - 35 of 35 in total
Human albumin microspheres
Approved
Experimental
Technetium Tc-99m albumin colloid
Approved
Experimental
Cryptenamine
Cryptenamine is a mixture of closely related hypotensive alkaloids from Veratrum album (Liliaceae). It has been used in the treatment of hypertension but has largely been replaced by drugs with fewer adverse effects. Cryptenamine has a marked and re-producible depressor effect when given intravenously to hypertensive patients, however the mechanism...
Approved
Matched Description: … Cryptenamine is a mixture of closely related hypotensive alkaloids from Veratrum album (Liliaceae). …
Alpinia officinarum leaf
Experimental
Matched Synonyms: … Alpinia officinarum leaf ... Languas officinarum leaf ... Alpinia officinarum leaf extract …
Matched Name: … Alpinia officinarum leaf …
Matched Name: … Alpinia officinarum leaf …
Hypericin
Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma.
Investigational
Matched Synonyms: … Hypericum red …
Albusomatropin
Albusomatropin has been used in trials studying the treatment of Growth Hormone-Deficiency and Growth Hormone Deficiency.
Investigational
Hyperforin
Hyperforin is a phytochemical generated by the plants of the Hypericum family. One of the most important members of this family, due to its medical properties, is Hypericum perforatum, also known as St John's wort.
Nutraceutical
Matched Description: … Hyperforin is a phytochemical generated by the plants of the Hypericum family. …
Albumin-stabilized nanoparticle (130 nm)
Investigational
Albinterferon Alfa-2B
Albumin-interferon alpha (Albuferon) is a novel, long-acting form of interferon alpha. Recombinant interferon alpha is approved for the treatment of hepatitis C, hepatitis B, and a broad range of cancers. Human Genome Sciences modified interferon alpha to improve its pharmacological properties by using the company's proprietary albumin fusion technology. Human...
Investigational
MM-111
MM-111 is a novel bispecific antibody fusion protein that co-targets the the epidermal growth factor family receptor tyrosine kinases, ERBB2 and ERBB3.
Investigational
Displaying drugs 26 - 35 of 35 in total